| Dr Nathan Chertack, MD | |
|
25 Hackett Blvd, Albany, NY 12208-3462 | |
| (518) 262-3341 | |
| Not Available |
| Full Name | Dr Nathan Chertack |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 25 Hackett Blvd, Albany, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568968600 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 322728 (New York) | Primary |
| Entity Name | Glens Falls Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336198217 PECOS PAC ID: 8325955974 Enrollment ID: O20031103000498 |
News Archive
Programmed death-ligand 1 is expressed by around 70% of small-cell lung cancers and is associated with favourable patient outcomes, Japanese researchers report.
Does the neighborhood where you live play a role in whether you become a smoker?
St. Jude Children's Research Hospital will lead a national Phase III clinical trial to investigate whether a new combination treatment can prevent a secondary stroke in children with sickle cell anemia (SCA) and eliminate the need for nightly injections with a drug that reduces iron overload in these patients.
A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer. In the December 8 issue of Cancer Cell, the research team describes finding that a gene called MAGP2 - not previously associated with any type of cancer - was overexpressed in papillary serous ovarian tumors of patients who died more quickly. They also found evidence suggesting possible mechanisms by which MAGP2 may promote tumor growth.
› Verified 9 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629008537 PECOS PAC ID: 1759293111 Enrollment ID: O20031125000386 |
News Archive
Programmed death-ligand 1 is expressed by around 70% of small-cell lung cancers and is associated with favourable patient outcomes, Japanese researchers report.
Does the neighborhood where you live play a role in whether you become a smoker?
St. Jude Children's Research Hospital will lead a national Phase III clinical trial to investigate whether a new combination treatment can prevent a secondary stroke in children with sickle cell anemia (SCA) and eliminate the need for nightly injections with a drug that reduces iron overload in these patients.
A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer. In the December 8 issue of Cancer Cell, the research team describes finding that a gene called MAGP2 - not previously associated with any type of cancer - was overexpressed in papillary serous ovarian tumors of patients who died more quickly. They also found evidence suggesting possible mechanisms by which MAGP2 may promote tumor growth.
› Verified 9 days ago
| Entity Name | Columbia Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083639587 PECOS PAC ID: 5092709410 Enrollment ID: O20040409000109 |
News Archive
Programmed death-ligand 1 is expressed by around 70% of small-cell lung cancers and is associated with favourable patient outcomes, Japanese researchers report.
Does the neighborhood where you live play a role in whether you become a smoker?
St. Jude Children's Research Hospital will lead a national Phase III clinical trial to investigate whether a new combination treatment can prevent a secondary stroke in children with sickle cell anemia (SCA) and eliminate the need for nightly injections with a drug that reduces iron overload in these patients.
A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer. In the December 8 issue of Cancer Cell, the research team describes finding that a gene called MAGP2 - not previously associated with any type of cancer - was overexpressed in papillary serous ovarian tumors of patients who died more quickly. They also found evidence suggesting possible mechanisms by which MAGP2 may promote tumor growth.
› Verified 9 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497921688 PECOS PAC ID: 1759293111 Enrollment ID: O20190320001621 |
News Archive
Programmed death-ligand 1 is expressed by around 70% of small-cell lung cancers and is associated with favourable patient outcomes, Japanese researchers report.
Does the neighborhood where you live play a role in whether you become a smoker?
St. Jude Children's Research Hospital will lead a national Phase III clinical trial to investigate whether a new combination treatment can prevent a secondary stroke in children with sickle cell anemia (SCA) and eliminate the need for nightly injections with a drug that reduces iron overload in these patients.
A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer. In the December 8 issue of Cancer Cell, the research team describes finding that a gene called MAGP2 - not previously associated with any type of cancer - was overexpressed in papillary serous ovarian tumors of patients who died more quickly. They also found evidence suggesting possible mechanisms by which MAGP2 may promote tumor growth.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nathan Chertack, MD 25 Hackett Blvd, Albany, NY 12208-3462 Ph: () - | Dr Nathan Chertack, MD 25 Hackett Blvd, Albany, NY 12208-3462 Ph: (518) 262-3341 |
News Archive
Programmed death-ligand 1 is expressed by around 70% of small-cell lung cancers and is associated with favourable patient outcomes, Japanese researchers report.
Does the neighborhood where you live play a role in whether you become a smoker?
St. Jude Children's Research Hospital will lead a national Phase III clinical trial to investigate whether a new combination treatment can prevent a secondary stroke in children with sickle cell anemia (SCA) and eliminate the need for nightly injections with a drug that reduces iron overload in these patients.
A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer. In the December 8 issue of Cancer Cell, the research team describes finding that a gene called MAGP2 - not previously associated with any type of cancer - was overexpressed in papillary serous ovarian tumors of patients who died more quickly. They also found evidence suggesting possible mechanisms by which MAGP2 may promote tumor growth.
› Verified 9 days ago
Dr. Jonah Marshall, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 319 S Manning Blvd Ste 106, Albany, NY 12208 Phone: 518-438-1019 Fax: 518-489-7642 | |
Rebecca Leigh O'malley, MD Urology Medicare: Medicare Enrolled Practice Location: 23 Hackett Blvd, Albany, NY 12208 Phone: 518-262-3341 Fax: 518-262-6660 | |
Brian Patrick Murray, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4 Executive Park, Albany, NY 12203 Phone: 518-489-7494 Fax: 518-489-7641 | |
Dr. Adam Shattuck Howe, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 23 Hackett Blvd # Mc-108, Albany, NY 12208 Phone: 518-262-3341 Fax: 518-262-6660 | |
Dr. Robert Charles Welliver Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 23 Hackett Blvd, Albany, NY 12208 Phone: 518-262-3341 Fax: 518-262-6660 | |
Jean G. Hollowell, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 23 Hackett Blvd, Mc 208, Albany, NY 12208 Phone: 518-262-3341 Fax: 518-262-6660 | |
Barry Kogan, Urology Medicare: Medicare Enrolled Practice Location: South Clinical Campus, 23 Hackett Blvd. (mc 208), Albany, NY 12208 Phone: 518-262-3341 |